Helen Hayes Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: New York City NY United States (1900)

Organization Overview

First Clinical Trial
1987
NCT00005006
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Helen Hayes Hospital, West Haverstraw, NY

Active Ingredients

Drugs in Phase 4 Trials (2)

denosumab (prolia) (1 trial)

teriparatide (5 trials)

Drugs in Phase 2 Trials (4)

alendronic acid (fosamax) (2 trials)

calcium (1 trial)

parathyroid hormone (Natpara) (2 trials)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 2)

Hip Fractures (Phase 2)

Osteoporosis (Phase 4)

Osteoporosis, Postmenopausal (Phase 2)

Osteoporotic Fractures (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6